NBIXNeurocrine BiosciencesHealth Care
$154.06EarningsOct 27, 2026
1D—1W—1M—3M—1Y—
Market cap$16.1BCompany infoRevenue$3.4B52-wk range$123 – $186IndustryBiotechnologyWebsiteneurocrine.comRelated—
Yahoo
EDGAR
CNN
FinvizMarket Beat
Perform
n/a
1 Year
n/a1 Month
n/a1 Week
n/a1 Day
Rank Durability
Persist
n/a
1 Year
n/a6 Month
n/a3 Month
n/aTrend Hold
Business Beat
Profit
n/a
Composite
n/aRevenue
n/aMargin
n/aCash Flow
Money Flow
Pressure
n/a
60 Day
n/a30 Day
n/a5 Day
n/a2 Day
▲ +15.7% · 1YSPY
Weekly rank vs S&P 500 · 52wk
Not enough history to plot
ValuationHow the price is priced — vs cohort and vs its own past
MetricValueUnivSect5-yr range
P / E22.6×5472
20
862
P / S4.8×3040
4
9
P / FCF18.4×5668
16
90
EV / EBITDA17.1×3748
14
193
P / E (fwd)———
ProfitabilityMargins and returns on capital
MetricValueUnivSect5-yr range
Gross margin98.0%9997
98%
99%
Operating margin23.4%7175
5%
26%
Net margin20.9%8083
1%
42%
ROE22.0%7077
1%
33%
ROIC16.0%7674
3%
16%
Financial healthLeverage and liquidity
MetricValueUnivSect5-yr range
Debt / equity0.009794
0.0
0.3
Net debt / EBITDA-0.4×7972
Current ratio1.876649
Interest coverage272.0×9086
Per shareTTM, with year-over-year change
Revenue / share$32.38▲ +34%
EPS (diluted)$6.82▲ +102%
FCF / share$8.35▲ +65%
Est. EPS growth (fwd)—